Evidence map›Paper›PMID 24135278›Full record

ArticleCancer cell2013

Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.

David L Waning, Khalid S Mohammad, Theresa A Guise

Open access · bronzeAbstract readComment
In one paragraph

Article in Cancer cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The role of microRNAs in bone metastasis.Journal of bone oncology · 2016
    Article
  6. Review
  7. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.International journal of clinical and experimental pathology · 2015
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David L WaningDivision of Endocrinology, Department of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Khalid S Mohammad
Theresa A Guise
Indiana University – Purdue University Indianapolis · US

Funding

TUMORS EFFECTS ON THE SKELETONP01CA040035 · NCI · VANDERBILT UNIVERSITY · PI SUN, LUZHE · 1985 to 2010
$11.0M
TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASISR01CA069158 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GUISE, THERESA A · 2001 to 2012
$2.8M
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor GrowthU01CA143057 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI BHOWMICK, NEIL A., GUISE, THERESA A · 2011 to 2015
$2.7M
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle.R21CA205437 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WANING, DAVID L · 2016 to 2017
$372k
NCI NIH HHS P01 CA040035NCI NIH HHS R01 CA069158NCI NIH HHS R01CA69158NCI NIH HHS U01 CA143057NCI NIH HHS U01CA143057
6 · The paper itself

Abstract

Tumor-bone cell interactions are critical for the development of metastasis-related osteolytic bone destruction. In this issue of Cancer Cell, Ell and colleagues show how a discrete miRNA network regulates osteoclastogenesis during breast cancer bone metastasis. A signature of upregulated miRNAs may have diagnostic and therapeutic implications for bone metastases.

Indexed as

AnimalsBiomarkers, TumorBone NeoplasmsHumansMicroRNAsOsteoclastsBiomarkers, TumorMicroRNAs

Identifiers

PMID24135278
PMCPMC3897244
OpenAlexW2090274273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.